NYSE$EHC
Encompass Health Corp · Q4 2020 earnings
Q4 2020 earnings · · Investor relations
Briefing
Reported results for the fourth quarter of 2020 and issued full-year 2021 guidance and longer term growth targets.
Encompass Health reported positive results for Q4 2020, demonstrating the resilience of its business model. The company successfully met the needs of patients, employees, and business partners throughout the year, and remains confident in its business and long-term prospects for 2021.
- Net operating revenues increased by 2.5% compared to Q4 2019.
- Income from continuing operations attributable to Encompass Health per diluted share increased by 26.5% compared to Q4 2019.
- Adjusted earnings per share increased by 9.4% compared to Q4 2019.
- Cash flows provided by operating activities increased by 29.7% compared to Q4 2019.
Headline financials
Revenue & EPS history
Encompass Health · Revenue · Quarterly
$1.21B
Forward guidance
The Company provided the following guidance for full-year 2021 and growth targets for 2020 through 2025. The Company's 2021 guidance and longer term growth targets assume the continuation of the current structure of the business. The guidance and growth targets may change depending on the ultimate outcome of the review.
Tailwinds
- Net operating revenues $5,000 to $5,170 million
- Adjusted EBITDA $925 to $955 million
- Adjusted earnings per share from continuing operations attributable to Encompass Health $3.31 to $3.53
- Net operating revenues 8% to 10% CAGR
- Adjusted EBITDA 8% to 10% CAGR
Headwinds
- Adjusted free cash flow 5% to 7% CAGR
- Base year 2020 adjusted free cash flow benefited from a temporary payroll tax holiday.
- Exclusive of this item, the adjusted free cash flow CAGR target would be 8% to 10%.
- The review is ongoing, and no decision has been made.
- The guidance and growth targets may change depending on the ultimate outcome of the review.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2020
+1.2%
Avg return
Earnings day
+1.6%
Avg return
5 days after
+2.5%
Avg return
30 days after
64%
42 / 66 earnings
Positive
+11.8%
Q1 2025
Best reaction
-9.0%
Q1 2015
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.1% | +5.0% | +6.0% | |
| Q4 2025 | +5.9% | +13.9% | +7.4% | |
| Q3 2025 | -6.9% | -6.8% | -7.5% | |
| Q1 2025 | +11.8% | +15.4% | +17.2% | |
| Q4 2024 | +1.3% | -0.6% | +0.7% | |
| Q3 2024 | +7.0% | +5.8% | +10.0% | |
| Q2 2024 | -8.7% | -7.5% | +1.0% | |
| Q1 2024 | +0.3% | +1.4% | +2.5% | |
| Q4 2023 | +1.7% | +1.9% | +5.9% | |
| Q3 2023 | -1.9% | +0.9% | +6.7% | |
| Q2 2023 | +5.0% | +6.4% | +7.6% | |
| Q1 2023 | +0.7% | -0.6% | -5.9% | |
| Q4 2022 | +1.6% | +3.1% | -9.1% | |
| Q3 2022 | +6.4% | +11.1% | +16.6% | |
| Q2 2022 | +0.6% | +4.5% | -4.0% | |
| Q1 2022 | +2.6% | +2.5% | -2.0% | |
| Q4 2021 | +1.5% | -2.9% | +8.8% | |
| Q3 2021 | -6.0% | -5.8% | -9.8% | |
| Q2 2021 | +0.7% | +3.5% | -4.1% | |
| Q1 2021 | -1.6% | -2.7% | -2.5% | |
| Q4 2020 | -3.9% | -6.2% | -6.1% | |
| Q3 2020 | -2.6% | -3.0% | +25.9% | |
| Q2 2020 | +4.5% | +3.1% | -6.4% | |
| Q1 2020 | -1.1% | -7.1% | +6.4% | |
| Q4 2019 | +0.4% | +3.1% | -2.6% | |
| Q3 2019 | -5.8% | +2.0% | +5.5% | |
| Q2 2019 | -4.0% | -7.4% | -12.6% | |
| Q1 2019 | +5.3% | +3.6% | -4.6% | |
| Q4 2018 | -4.4% | -3.5% | -13.3% | |
| Q3 2018 | -5.7% | -4.0% | +1.4% | |
| Q2 2018 | +8.8% | +5.9% | +17.4% | |
| Q1 2018 | +7.2% | +7.3% | +10.3% | |
| Q4 2017 | +3.0% | +3.9% | +7.7% | |
| Q3 2017 | +1.8% | +2.0% | +8.7% | |
| Q2 2017 | +1.9% | -0.2% | +3.6% | |
| Q1 2017 | +7.9% | +10.0% | +6.3% | |
| Q4 2016 | +0.1% | +0.5% | -1.9% | |
| Q3 2016 | +1.8% | +0.7% | +5.6% | |
| Q2 2016 | +6.7% | +3.1% | -0.3% | |
| Q1 2016 | +10.9% | — | — | |
| Q4 2015 | +9.2% | — | — | |
| Q3 2015 | -0.3% | — | — | |
| Q2 2015 | -2.9% | — | — | |
| Q1 2015 | -9.0% | — | — | |
| Q4 2014 | -4.7% | — | — | |
| Q3 2014 | -3.0% | — | — | |
| Q2 2014 | +7.4% | — | — | |
| Q1 2014 | -0.4% | — | — | |
| Q4 2013 | -2.8% | — | — | |
| Q3 2013 | +0.6% | — | — | |
| Q2 2013 | +4.7% | — | — | |
| Q1 2013 | +3.1% | — | — | |
| Q4 2012 | +7.2% | — | — | |
| Q3 2012 | +2.5% | — | — | |
| Q2 2012 | -3.7% | — | — | |
| Q1 2012 | +9.2% | — | — | |
| Q4 2010 | +3.9% | — | — | |
| Q4 2011 | +3.9% | — | — | |
| Q3 2011 | -1.0% | — | — | |
| Q2 2011 | -9.0% | — | — | |
| Q1 2010 | +0.4% | — | — | |
| Q1 2011 | +2.5% | — | — | |
| Q4 2008 | +7.8% | — | — | |
| Q3 2010 | +2.2% | — | — | |
| Q2 2010 | -1.0% | — | — | |
| Q4 2009 | -1.0% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro